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INTRODUCTION
Hypertension is very common in patients receiving hemodialy-
sis (1, 2), and it is an important risk factor for cardiovascular dis-
eases (3, 4). Cardiovascular disease is responsible for approximately
half the deaths of patients receiving hemodialysis (5). Although
approximately 86% of patients receiving hemodialysis with hyper-
tension take antihypertensive drugs, only 30% have well -controlled
blood pressure (BP). (6). Thus, despite the high rate of antihy-
pertensive drug use, BP control remains unsatisfactory. In addition
to BP, interdialytic weight gain (IDWG) is also a useful prognostic
marker for kidney failure. The United States Renal Data System
study found that a high IDWG was associated with shorter survival
(7). Furthermore, a report in Japan revealed that survival was lower
if the IDWG to dry weight ratio was2% or6% (8).
Hypertension is closely related to IDWG (9) ; it is therefore
important to reduce IDWG to improve hypertension in patients
receiving hemodialysis. IDWG is generally considered to be a
consequence of salt and water intake between two consecutive
dialysis sessions. Excessive salt and water intake expands extracel-
lular volume, thereby increasing the risk of developing hyperten-
sion and left ventricular hypertrophy. Salt restriction with reduced
use of antihypertensive drugs to manage high BP may reduce the
prevalence of left ventricular hypertrophy and left ventricular
dysfunction in hemodialysis patients (10-12). However, few sys-
tematic studies have demonstrated that dietary therapy or nutri-
tional counseling have beneficial effects on hypertension and IDWG
in Japan. Therefore, we investigated whether long-term nutritional
counseling by a nationally registered dietitian could improve IDWG
and blood pressure in hemodialysis patients.
METHODS
Patient selection
All of the patients who participated in the study received hemo-
dialysis at Kawashima Hospital (Tokushima, Japan). The concen-
tration of dialysate sodium during hemodialysis was maintained
at 140 mEq/L in accordance with standard methods. Eligibility cri-
teria for the study included : (i) IDWG ratio5.1%, the clinical
parameter of Kawashima Hospital ; (ii) receiving hemodialysis
therapy without regular nutritional counseling in Kawashima Hos-
pital for5 years ; (iii) receiving hemodialysis routinely three
times/week (scheduled as 12 hours/week) ; (iv) receiving hemo-
dialysis for5 years ; and (v) no residual renal function for5
years. Fifty - five patients met the eligibility criteria out of 469 hemo-
dialysis outpatients at Kawashima Hospital. Seven patients were
excluded for the following reasons : one patientdied, two changed
hospitals, and four had a long hospitalization of1 month during
the study. Theremaining 48 patients participated in the study.
Data collection
We collected the following clinical data from the patients’ medi-
cal records during both the control (the 48-month period prior to
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the beginning of the intervention period) and intervention periods :
sex, age, duration of hemodialysis, diabetes mellitus status, height,
dry weight, IDWG, and normalized protein catabolic rate (nPCR).
We also recorded antihypertensive drug use. We measured body
weight with a scale. Dry weight was the post-dialysis body weight
below which the patient developed symptomatic hypotension or
muscle cramps in the absence of edema.
We measured pre- and post-dialysis systolic and diastolic BP
with an aneroid sphygmomanometer. BP was averaged from three
hemodialysis sessions at the end of each month. Measurements
were classified based on the 2004 Japanese Society of Hyperten-
sion guidelines (13). Intradialytic hypotensive episodes were de-
fined as a decrease in systolic BP of20 mmHg requiring saline
infusion. We recorded symptomatic intradialytic hypotensive epi-
sodes that occurred during the 12 hemodialysis sessions at the
beginning of each month on the patients’ charts for 6 months.
We defined IDWG as body weight just before hemodialysis minus
body weight just after previous hemodialysis. The IDWG ratio was
calculated as follows : IDWG ratio (%)=average of 12 measure-
ments (three times/week4 weeks) of IDWG/dry weight100.
We defined a decrease or increase in the IDWG ratio as a change
of0.5% at 48 months compared to the start of the intervention
period, and we defined a decrease or increase in the dosage of
medicated antihypertensive drugs as a change at 48 months com-
pared to the start of the intervention period. Borah’s formula was
used to calculate the PCR (14). This method adds the measured
dialysis protein loss to the measured urine and dialysis urea ap-
pearance rate. The latter is adjusted to obtain the PCR by a function
of the linear correlation between the urea appearance rate and the
PCR calculated from nitrogen mass balance measurements in
hemodialysis patients. We then divided the PCR value by the
patient’s dry weight (kg) to yield the nPCR, measured as g/kg (dry
weight)/day. The estimated salt intake was calculated with Kimura’s
formula (15) as follows : estimated salt intake (g/day)=interdia-
lytic sodium intake (mmol)58.5/100024/hours from previous
post-dialysis to pre-dialysis, where interdialytic sodium intake
(mmol)+1=(serum sodium concentration of pre-dialysistotal
body fluid volume of pre-dialysis) -(serum sodium concentration
of previous post-dialysistotal body fluid volume of previous post-
dialysis)+1.
Estimated water intake was calculated as follows : estimated
water intake (mL/day)=body weight gain for a week (g)water
density (ml/g)/6.5 (day)+volume of insensible water loss+esti-
mated water volume in stool=body weight gain for a week/6.5+
15dry weight+200. Estimated water intake except food was
calculated as follows : estimated water intake except food (mL/
day)=estimated water intake (mL/day)-volume of water in the
food intake (mL/day)=estimated water intake (mL/day)-1000
(mL/day)
Nutritional counseling intervention
Before we beganthe nutritional counseling intervention, we made
a checklist of each potential area of concern, such as salt and/or
fluid restriction, to ensure that the counseling intervention was
standardized. The written materials used for counseling were pro-
vided by each registered dietitian.
We started offering nutritional counseling in June 2002. At each
session, the registered dietitian assessed the patient’s clinical data
to identify potential problems. The dietitian then provided the pa-
tient with monthly nutritional counseling at their bedside during
hemodialysis. The educational contents of the dietitian to each
patient were the following items : relationship between sodium
and IDWG, sodium and/or water-rich foods, high-calorie foods,
and so on. For example, we advised that they had better to avoid
taking miso soup, one-pot cooking and stock sauce for noodle,
while they had better to consume seasoning without salt. If the
patient’s clinical data had not improved by the next session, the
dietitian made a special effort to listen carefully to the patient to
determine how best to assist them.
At the beginning of the nutritional counseling intervention, we
set the target reduction in salt and water intake to 1.5 g/day (about
1 cup of miso soup or 1 pickled plum) and 200 ml/day (1 cup of
water), respectively. Nutritional counseling sessions lasted for an
average of 20 minutes/session. The nutritional counseling inter-
vention continued monthly for 4 years.
Ethical considerations
The study was approved by the Kawashima Hospital Ethics
Committee, and informed consent was obtained from all patients.
The study was designed to be a prospective observational study
withselfandhistoricalcontrol.
Statistical analysis
We performed statistical analyses with Excel Statistics 2006
(Microsoft Japan, Tokyo, Japan) for Windows. Data are expressed
as the meanstandard deviation (SD) of 48 individual outpatients.
Paired t - test was used to analyze differences in the IDWG ratio and
pre-dialysis systolic or diastolic BP. A P value of0.05 (two-sided)
was considered significant. The Cochran-Armitage test was used
to analyze the correlation between the dosage of antihypertensive
drugs and the IDWG ratio. A P value of0.05 (two-sided) and
Cramer’s coefficient of association (Cramer’s V-value) of 0V1
were considered significant.
RESULTS
General clinical data
Table 1 lists the subjects’ baseline clinical data. There were ap-
proximately 1.7 times more men than women ; 63% of the men
received nocturnal dialysis and worked. The subjects were on
average 10 years younger the average age of the patients in the
2005 report of The Japanese Society for Dialysis Therapy (2). The
average BMI of the subjects was 20.92.6, close to the standard
value of 22 kg/m2. The IDWG ratio was 1% higher than the IDWG
clinical parameter used at Kawashima Hospital. The nPCR was
1.190.17 g/kg/day, which met the criteria of the Japanese So-
ciety for Dialysis Therapy. The ratio of antihypertensive drug use
and pre- or post-dialysis BP was similar to the measurements re-
ported in 2005 by the Japanese Society for Dialysis Therapy, except
for post-dialysis systolic BP. The primary diseases of the study par-
ticipants were as follows : chronic glomerulonephritis (29/48),
type II diabetes mellitus (9/48), toxemia of pregnancy (3/48),
polycystic kidney disease (1/48), chronic pyelonephritis (1/48),
obstructive uropathy (1/48), and cause unknown (4/48). We did
not observe any cases of hypertensive nephrosclerosis. During the
control period, most of the subjects had not received nutritional
counseling.
Changes in salt and water intake
Salt and water intake increased significantly from 48 months
prior to the intervention period (-48 months) to the beginning of
the intervention period (0 months). After 48 months of intervention
(48 months), salt and water intake had decreased significantly com-
pared to 0 months, but it did not decrease to the level noted at -48
months (Table 2).
Changes in the interdialytic weight gain ratio
The participants’ mean IDWG ratio increased with repeated sea-
sonal variations during the control period. We did not observe a
significant decrease in the IDWG ratio until 6 months after the in-
tervention period had started. After 12 months, the IDWG continued
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to decrease significantly with repeated seasonal variations (Figure 1).
Changes in pre-dialysis blood pressure and antihypertensive
drug use
BP remained near constant during the control period (Figure 2),
but the number of antihypertensive drugs increased (Figure 3A).
However, we observed a significant decrease in BP 24 months into
the intervention period (Figure 2), and the percentage of partici-
pants taking two or more antihypertensive drugs decreased from
45.8 to 18.7% after 48 months (Figure 3A). The percentage of
patients who did not need antihypertensive drugs decreased by
approximately 20%, from 58.2 to 37.5%, at 0 months compared to
-48 months. However, 48 months into the intervention, half of the
subjects no longer required antihypertensive drugs. In the pre-
intervention control period, use of all types of antihypertensive
drugs increased. Once the intervention period began, use of all
types of antihypertensive drugs decreased, except for angiotensin
II -receptor blockers (ARB) (Figure 3B).
Changes in cardiothoracic ratio, dry weight, normalized protein
catabolic rate, and hemoglobin A1c
The mean cardiothoracic ratio was similar at -48, 0, and 48
months : 494.7, 50.34.9, and 49.54.8%, respectively. We did
not observe any edema in the participants at any of these times. Dry
weight did not change significantly at -48, 0, and 48 months : 54.8
9.4, 54.69.9, and 54.29.6 kg, respectively. The nPCR also re-
mained nearly the same (Table 2). The mean hemoglobin A1c of
the patients decreased slightly, but the change was not significant :
6.41.1, 6.31.0, and 6.00.5%, respectively, at -48, 0, and 48
months.
Classification of participants based on 2009 Japanese Society
of Hypertension guidelines, and frequency of hypotension
We classified the subjects in accordance with the Japanese Soci-
ety of Hypertension Guidelines 2009 (Table 3). The percentage of
patients with normal BP decreased to less than half during the
control period. This was a far lower rate than that reported by the
Japanese Society for Dialysis Therapy. Moreover, patients with
high-normal BP increased 1.6- fold and patients with III grade
hypertension increased 2.5- fold during the control period. After
48 months of intervention, none of the participants had grade III
hypertension. Furthermore, the percentage of patients with grade
II hypertension decreased to approximately one-fifth and the per-
centage of patients with normal blood pressure increased approxi-
mately 4- fold. The mean frequency of hypotension during 12 con-
secutive dialysis sessions (three times/week4 weeks) was 2.3
3.0, 2.42.9, and 2.52.9 times at -48, 0, and 48 months, respec-
tively. The change in the mean frequency was no significant.
Correlation between weekly dosage of antihypertensive drugs and
interdialytic weight gain ratio
Both increased and decreased antihypertensive drug dosages
significantly correlated with the IDWG ratio after 48 months of in-
tervention compared to 0 months (Table 4). The IDWG of seven
Table 1. Baseline clinical data of the study participants.
Characteristics Values JSDT2005
Men/women 30/18
Age, years 52.99.7 63.912.8
Duration of hemodialysis, years 12.25.7
Diabetes mellitus 11 (23) (31)
Height, cm 161.49.0
Dry weight, kg 54.69.9
Body mass index, kg/m2 20.92.6
Interdialytic weight gain ratio, % 6.00.7
Normalized protein catabolic rate, g/kg/day 1.190.17
Antihypertensive drug use
Blood pressure 30 (63) (66)
Pre -dialysis systolic, mmHg 14919 15324
Pre-dialysis diastolic, mmHg 8213 7914
Post -dialysis systolic, mmHg 12718 13925
Post -dialysis diastolic, mmHg 727 7414
Values are meanstandard deviation or n (%) of 48 patients.
JSDT2005, The 2005 report from The Japanese Society for Dialysis Therapy.
Table 2. Effects of nutritional counseling on normalized protein catabolic rate (nPCR) and estimated salt and water
intake.
-48 months 0 months 48 months
nPCR, g/kg/day 1.160.15 1.190.17 1.140.17
Estimated salt intake, g/day 10.73.0* 13.32.7 11.82.4*
Standardized estimated salt intake, g/kg of dry weight/day 0.200.04 0.240.03 0.220.04
Estimated water intake, mL/day 2209463* 2528455 2332410*
Standardized estimated water intake except food, ml/kg of dry
weight/day 226* 284 245*
*P0.05 between 0 months and -48 months or 48 months.
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female participants did not decrease. These subjects were under-
weight (BMI 18.51.6 kg/m2) and did not have diabetes.
DISCUSSION
Despite the high prescription rate for antihypertensive drugs
among patients receiving dialysis, most have poor control of their
BP. In Japan, pre-dialysis BP is as high as 15324/7914 mmHg
in 66% of dialysis patients who are taking antihypertensive drugs
(2). We included maintenance hemodialysis patients whose IDWG
ratios were5.1% in the present study. However, 63% of these
patients took antihypertensive drugs. Several studies (10-12) have
reported that patients can control their BP without antihyperten-
sive drug use by strict restriction of salt and water intake. There-
fore, we investigated whether long-term nutritional counseling by
nationally registered dietitians could improve IDWG and BP in
patients receiving hemodialysis.
During counseling sessions in which we offered nutritional guid-
ance on salt and water restrictions, we paid marked attention to
whether nPCR and dry weight were maintained properly, because
there is a close relationship between IDWG and nutritional status
in hemodialysis patients (16). Moreover, IDWG and nPCR values
decrease over long interdialytic intervals (17). This indicates that
many hemodialysis patients intentionally reduce food intake to con-
trol their IDWG, which could lead to malnutrition.
Figure 1. Changes in the interdialytic weight gain ratio during the control and intervention periods. Values are meanstandard deviation of 48
patients. *P0.05 compared to 0 months.
Figure 2. Changes in pre -dialysis systolic and diastolic blood pressure during the control and intervention periods. Values are meanstandard
deviation of 48 patients. *P0.05 compared to 0 months.
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Figure 3. The percentage of patients taking number (A) and types (B) of prescribed antihypertensive drugs during the control and intervention
periods. ACE, angiotensin -converting enzyme ; ARB, angiotensin II receptor blocker.
Table 3. Classification of outpatients based on The Japanese Society of Hypertension guidelines 2009.
-48 months 0 months 48 months JSDT2005
Normal blood pressure (130/85 mmHg) 18.8 8.3 33.2 14.5
High normal blood pressure
(systolic130-139 or diastolic85-89 mmHg) 10.4 16.7 31.3 11.2
Grade I hypertension
(systolic140-159 or diastolic90-99 mmHg) 43.7 41.7 31.3 32.5
Grade II hypertension
(systolic160-179 or diastolic100-109 mmHg) 22.9 22.9 4.2 26.9
Grade III hypertension
(systolic180 or diastolic110mmHg) 4.2 10.4 0.0 14.9
Values are presented as percentages of 48 patients.
JSDT2005, The 2005 report from The Japanese Society for Dialysis Therapy.
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During the control period, the subjects’ mean IDWG increased,
and repeated seasonal variations occurred. However, the mean
IDWG gradually decreased after intervention by a dietitian, al-
though the repeated seasonal variations continued. Thus, this
change during the control period is an effect of increased and
decreased perspiration due to changes in the temperature.
The beneficial effect that nutritional counseling significantly de-
creased the IDWG is partially explained by “the health belief model”
devised by Rosenstock et al. (18, 19). In this model, the patients’
sense that a health crisis is occurring will cause them to reduce
their salt and water intake for a short time. However, when they
perceived the unpleasant effects of restricted salt and water intake
greater than its health benefits for a long time, they allowed them-
selves to receive the diets non-restricted salt and water. The nutri-
tional counseling helps them to keep it in the mind that a health
crisis was progressing even if they did not feel receiving beneficial
effects from the diet restricted salt and water.
The estimated salt and water intake after 48 months of inter-
vention was far from the dietary standards (The salt intake was less
than 0.15 g/kg dry weight/day, and the water intake was less than
15 ml/kg dry weight/day) of Japanese Society of Nephrology in
1997, when our project started. However, this limitation was very
difficult for peoples eating the diet non-restricted salt and water
to complete. Therefore, we considered it necessary to optimize
programs for longer- term follow-ups and nutritional counseling.
Therefore, our initial targets of reducing salt intake and water
intake were set at 1.5 g/day and 200 ml/day, respectively, which
approximately correspond to the salt amount in 200 ml miso soup,
and realized. In the present study, such mild limitation of salt and
water intake was able to decrease the mean vale of IDWG of our
hemodialysis out patients. In addition, our participants continued
to keep this limitation of salt and water intake even after the study.
Thus, we recommend that the limitation of salt and intake for hemo-
dialytic outpatients should not be too strict.
Hemodialysis patients with diabetes can improve their IDWG
by controlling blood glucose (20). In this study, the hemoglobin
A1c percentage in diabetic patients did not change significantly
over the course of 8 years. However, current guidelines recom-
mend the use of glycoalbumin values to manage blood glucose in
diabetic patients undergoing dialysis. However, our intervention
period took place when blood glucose was still being managed
based on hemoglobin A1c levels ; thus, we are uncertain whether
blood glucose was strictly managed. For hemodialysis patients
with diabetes mellitus, it may be necessary to augment nutritional
counseling to include information about managing blood glucose.
Our underweight female participants found it difficult to decrease
their IDWG. Thin hemodialysis patients have more severe salt and
water restrictions than other patients and may benefit more from
high-calorie and -protein diets than strict salt and water restric-
tions. In our study, although the percentage of patients taking mul-
tiple antihypertensive drugs increased, the number of subjects
with normal BP decreased and the number of patients with grade
III hypertension patients increased in the control period. As re-
ported in previous studies (21), patients receiving hemodialysis
may have difficulty lowering their BP, even if they are taking multi-
ple antihypertensive drugs. Two years into the intervention period,
the mean pre-dialysis systolic BP had decreased significantly. Con-
currently, the percentage of patients taking multiple antihyper-
tensive drugs decreased. This result is in concordance with that of
a previous study (10-12), which found that salt and water restric-
tions are important in the treatment of hypertensive hemodialysis
patients.
Agarwal et al. (22) reported that it is important for BP manage-
ment of hemodialysis patients to measure their BP at home. How-
ever, our study began before their results were published and thus
most of our patients did not measure their BP at home. In the fu-
ture, it may be beneficial to tailor counseling on the basis of the
results of home BP monitoring. Moreover, in this study, few pa-
tients underwent ongoing echocardiographic examinations. Thus,
we could not investigate changes in cardiac function. We hope to
do so in future studies.
CONCLUSION
Our findings suggest that long-term nutritional counseling by
a nationally registered dietitian may improve the IDWG ratio and
BP of hemodialysis patients by decreasing their salt and water
intake.
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